Skip to main content
Clean Science and Technology Limited logo

Clean Science and Technology Limited — Investor Relations & Filings

Ticker · CLEAN ISIN · INE227W01023 LEI · 335800ONLA5LRUZJZB84 BSE.NS Manufacturing
Open in API
Filings indexed 481 across all filing types
Latest filing 2023-06-30 Regulatory Filings
Country IN India
Listing BSE.NS CLEAN

About Clean Science and Technology Limited

https://cleanscience.co.in/

Clean Science and Technology Limited specializes in the development and manufacture of specialty chemicals using sustainable and eco-friendly catalytic processes. The company focuses on green chemistry to produce high-purity performance chemicals, pharmaceutical intermediates, and FMCG ingredients. Key products include Monomethyl Ether of Hydroquinone (MEHQ), Butylated Hydroxyanisole (BHA), Ascorbyl Palmitate, Guaiacol, and 4-Methoxy Acetophenone (4-MAP). These products serve diverse global applications in the food, pharmaceutical, and personal care sectors. The company leverages proprietary technology and atom-efficient manufacturing routes to minimize waste and environmental impact, establishing itself as a global leader in several niche chemical segments through cost-effective and innovative production methodologies.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window for insiders ahead of the announcement of the company's unaudited financial results for the quarter ended June 30, 2023. It references the upcoming board meeting for approval of these results but does not contain any financial data or the results themselves. The document is brief (1419 characters) and serves as an announcement related to regulatory compliance under SEBI insider trading regulations. Therefore, it is not a financial report, earnings release, or detailed management report. It fits best under Regulatory Filings (RNS) as a compliance-related announcement that does not fit other specific categories.
2023-06-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 29.06.2023 addressed to stock exchanges about the schedule of an investor meeting. It references SEBI Listing Regulations and states that no unpublished price sensitive information will be discussed. The content is an announcement of a meeting schedule rather than a financial report or detailed presentation. The document length is only 1621 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and does not qualify as an Investor Presentation (IP) or any financial report type.
2023-06-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 20.06.2023 addressed to stock exchanges regarding the schedule of an investor meeting. It references compliance with SEBI Listing Regulations and states that no unpublished price sensitive information will be discussed. The content is an announcement of a meeting schedule rather than a financial report, earnings release, or detailed investor presentation. The document length is only 1622 characters, indicating it is a brief announcement. There is no financial data, no detailed report, and no voting or management changes mentioned. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for miscellaneous filings that do not fit other specific categories.
2023-06-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 17.06.2023 addressed to stock exchanges regarding the schedule of investor meetings. It references compliance with SEBI Listing Regulations and discloses planned interactions with institutional investors. There is no financial data, no detailed report, no voting results, no management changes, and no legal or audit information. The document is an announcement of scheduled investor meetings, which is a regulatory disclosure but does not fit into categories like earnings release or investor presentation. Given the short length (1733 characters) and the nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-06-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 17.06.2023 addressed to stock exchanges regarding the schedule of an investor meeting. It references compliance with SEBI Listing Regulations and states that no unpublished price sensitive information will be discussed. The content is an announcement of a meeting schedule rather than a financial report, earnings release, or detailed investor presentation. The document length is only 1614 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2023-06-17 English
Updates
Regulatory Filings
2023-05-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.